Purinergic receptor P2Y2 |
EC50 |
= |
1450.0 |
nM |
Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay |
CHEMBL1150771 |
Pyrimidinergic receptor P2Y4 |
EC50 |
= |
1260.0 |
nM |
Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay |
CHEMBL1150771 |
Pyrimidinergic receptor P2Y6 |
Activity |
|
|
|
Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation at 10 uM by scintillation proximity assay |
CHEMBL1150771 |
Unchecked |
Ratio IC50 |
= |
102.0 |
|
Selectivity ratio of IC50 for HCV genotype 1b NS5B RNA dependent RNA polymerase S282T mutant to IC50 for wild-type HCV genotype 1b NS5B RNA dependent RNA polymerase |
CHEMBL4043192 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
8240.0 |
nM |
Inhibition of HCV genotype 1b NS5B RNA dependent RNA polymerase S282T mutant |
CHEMBL4043192 |
Unchecked |
IC50 |
= |
81.0 |
nM |
Inhibition of wild-type HCV genotype 1b NS5B RNA dependent RNA polymerase |
CHEMBL4043192 |
Nonstructural protein 5 |
IC50 |
= |
5000.0 |
nM |
Inhibition of Dengue virus RdRp activity using 5'-(TCAG)20(TCCAAG)14(TCAG)20-3' as template measured after 120 mins |
CHEMBL4118212 |
DNA-directed RNA polymerase, mitochondrial |
Activity |
= |
29.4 |
% |
Inhibition of human POLRMT using 5'-FAM labelled RNA primer/DNA template duplex assessed as single nucleotide incorporation rate at 500 uM after 5 mins by SDS-PAGE analysis relative to control |
CHEMBL4118212 |
DNA polymerase alpha subunit |
Inhibition |
= |
22.4 |
% |
Inhibition of human DNA polymerase-alpha assessed as reduction in [3H]dTTP incorporation in to activated calf thymus DNA substrate at 100 uM by scintillation counting method relative to control |
CHEMBL4393666 |
DNA polymerase beta |
Inhibition |
= |
-0.008 |
% |
Inhibition of human DNA polymerase-beta assessed as reduction in [3H]dTTP incorporation in to activated calf thymus DNA substrate at 100 uM by scintillation counting method relative to control |
CHEMBL4393666 |
DNA polymerase gamma subunit 1 |
Inhibition |
= |
14.6 |
% |
Inhibition of human DNA polymerase-gamma assessed as reduction in [3H]dTTP incorporation in to activated calf thymus DNA substrate at 100 uM by scintillation counting method relative to control |
CHEMBL4393666 |
Unchecked |
IC50 |
> |
100000.0 |
nM |
Inhibition of RNA polymerase 2 in human HeLa cell nuclear extract assessed as reduction in RNA transcription by PAGE analysis |
CHEMBL4393666 |
DNA-directed RNA polymerase, mitochondrial |
Inhibition |
|
|
% |
Inhibition of human mitochondrial DNA-dependent RNA polymerase activity at 100 uM using 33P-RNA/DNA primer/template by phosphor-imaging analysis |
CHEMBL4393666 |
DNA-directed RNA polymerase, mitochondrial |
Activity |
= |
9.8 |
% |
Substrate activity at human POLRMT assessed as 5-radiolabled RNA/DNA incorporation levels at 100 uM after 2 hrs by PAGE analysis |
CHEMBL4411318 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
63.0 |
nM |
Inhibition of NS5B polymerase in HCV genotype 1b infected in human HuH7 replicon cells after 96 hrs by RT-PCR analysis |
CHEMBL4411318 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
25.0 |
nM |
Inhibition of NS5B polymerase in HCV genotype 1a infected in human HuH7 replicon cells after 96 hrs by RT-PCR analysis |
CHEMBL4411318 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
47.0 |
nM |
Inhibition of NS5B polymerase in HCV genotype 3a infected in human HuH7 replicon cells after 96 hrs by RT-PCR analysis |
CHEMBL4411318 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
47.0 |
nM |
Inhibition of NS5B polymerase in HCV genotype 6a infected in human HuH7 replicon cells after 96 hrs by RT-PCR analysis |
CHEMBL4411318 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
36000.0 |
nM |
Inhibition of NS5B polymerase S282T mutant in HCV genotype 1b infected in human HuH7 replicon cells after 96 hrs by RT-PCR analysis |
CHEMBL4411318 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
190.0 |
nM |
Inhibition of NS5B polymerase in HCV genotype 2a infected in human HuH7 replicon cells after 96 hrs by RT-PCR analysis |
CHEMBL4411318 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
70.0 |
nM |
Inhibition of NS5B polymerase in HCV genotype 4a infected in human HuH7 replicon cells after 96 hrs by RT-PCR analysis |
CHEMBL4411318 |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
= |
97.0 |
nM |
Inhibition of NS5B polymerase in HCV genotype 5a infected in human HuH7 replicon cells after 96 hrs by RT-PCR analysis |
CHEMBL4411318 |
Unchecked |
Ratio IC50 |
= |
0.75 |
|
Selectivity ratio of IC50 for HCV genotype 3a NS5B polymerase to IC50 for wild type HCV genotype 1b NS5B polymerase |
CHEMBL4411318 |
Unchecked |
Ratio IC50 |
= |
1.1 |
|
Selectivity ratio of IC50 for HCV genotype 4a NS5B polymerase to IC50 for wild type HCV genotype 1b NS5B polymerase |
CHEMBL4411318 |
Unchecked |
Ratio IC50 |
= |
1.5 |
|
Selectivity ratio of IC50 for HCV genotype 5a NS5B polymerase to IC50 for wild type HCV genotype 1b NS5B polymerase |
CHEMBL4411318 |
Unchecked |
Ratio IC50 |
= |
0.75 |
|
Selectivity ratio of IC50 for HCV genotype 6a NS5B polymerase to IC50 for wild type HCV genotype 1b NS5B polymerase |
CHEMBL4411318 |
Unchecked |
Ratio IC50 |
= |
0.4 |
|
Selectivity ratio of IC50 for HCV genotype 1a NS5B polymerase to IC50 for wild type HCV genotype 1b NS5B polymerase |
CHEMBL4411318 |
Unchecked |
Ratio IC50 |
= |
3.0 |
|
Selectivity ratio of IC50 for HCV genotype 2a NS5B polymerase to IC50 for wild type HCV genotype 1b NS5B polymerase |
CHEMBL4411318 |
Unchecked |
Ratio IC50 |
= |
570.0 |
|
Selectivity ratio of IC50 for HCV genotype 1b NS5B polymerase S282T mutant to IC50 for wild type HCV genotype 1b NS5B polymerase |
CHEMBL4411318 |